Format

Send to

Choose Destination
Gynecol Oncol. 2004 Jul;94(1):212-6.

Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women.

Author information

1
Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA. junger@lsuhsc.edu

Abstract

OBJECTIVE:

To determine the ability of whole-body [(18)F]fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) scan to detect recurrent cervical carcinoma in both symptomatic and asymptomatic women.

MATERIALS AND METHODS:

We retrospectively reviewed the records of 44 women previously treated for cervical cancer who underwent 47 posttreatment whole-body FDG PET scans in an attempt to detect recurrent disease. Twenty-six scans were performed in asymptomatic women, whereas 21 scans were performed in women with symptoms suggestive of recurrence.

RESULTS:

About 30.8% of asymptomatic women had recurrent disease detected by PET scan compared to 66.7% of women in the symptomatic group. The sensitivity of PET scan for recurrent disease in asymptomatic women was 80.0%, specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 88.9%. For symptomatic women, the sensitivity of PET was 100%, specificity of 85.7%, a positive predictive value of 93.3%, and a negative predictive value of 100%.

CONCLUSIONS:

The whole-body FDG PET scan is a sensitive imaging modality for the detection of recurrent cervical carcinoma in both symptomatic and asymptomatic women.

PMID:
15262145
DOI:
10.1016/j.ygyno.2004.04.021
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center